Dr Zelma Chiesa Fuxench | CureTalks
Dr Zelma Chiesa Fuxench is a clinical instructor at the University of Pennsylvania Perelman School of Medicine. She is a board-certified dermatologist whose clinical work focuses on general dermatology, non-melanoma skin cancer and inflammatory diseases. Her research work is focused on the epidemiology of inflammatory skin diseases and is actively involved in the conduction of clinical trials on psoriasis and atopic dermatitis as part of Dr. Gelfand’s Clinical Research Lab. Dr. Chiesa Fuxench received her undergraduate degree in biology from the University of Puerto Rico ((Magna Cum Laude), and her medical degree from the University of Puerto Rico School of Medicine (Magna Cum Laude). Dr. Chiesa Fuxench completed an internship in internal medicine at the University District Hospital, San Juan, Puerto Rico, and her dermatology residency at the University of Puerto Rico School of Medicine. She is currently enrolled in the Master’s in Science Clinical Epidemiology from the University of Pennsylvania Perelman School of Medicine and her thesis project is on the risk of non-melanoma skin cancers in users on antihypertensive medications. Dr. Chiesa Fuxench’s career has been supported by grants from the National Institutes of Health, National Psoriasis Foundation and the Dermatology Foundation. She is a member of multiple societies and organizations including the American Academy of Dermatology, Society for Investigative Dermatology. International Society for Pharmacoepidemiology, American Medical Association, the International Skin Cancer Transplant Collaborative and the Puerto Rico Society of Dermatology, among others. Dr. Chiesa Fuxench’s ultimate goal is to provide excellent patient care as well as to continue to develop her career as an expert in the care of patients with inflammatory skin disease.
Related Talks
Understanding Atopic Dermatitis and Treating It.
Atopic dermatitis, also known as eczema is a chronic skin condition that is estimated to affect between 10-20% of children but often appears…